Skip to content
  • Home
  • IOncology
  • Infectious Desease Frontier
  • IHepatology
  • Hematology Frontier
  • Conference topics
  • Experts Interviews
  • Informations
  • Live Broadcasting
  • Logout
MediaMedic

Connecting Medical Expertise through Media

  • Home
  • IOncology
  • Infectious Disease Frontier
  • International Hepatology
  • Hematology Frontier
  • Conference topics
  • Experts’ Interviews
  • Informations
  • Home
  • IOncology
  • Infectious Disease Frontier
  • International Hepatology
  • Hematology Frontier
  • Conference topics
  • Experts’ Interviews
  • Informations

Informations

Home » Informations
  • Prof. Lin Visits MGH | Talk with Prof. Lori Wirth on Targeted Therapy for Advanced Thyroid Cancer

    Join us for an exclusive conversation between Prof. Yansong Lin of Peking Union Medical College Hospital and Prof. Lori Wirth at Massachusetts General Hospital. In this special academic exchange, the…

    2025.05.08
  • Redefining Standards in Urothelial Cancer: A Conversation with Dr. Thomas Powles

    In this exclusive UroStream interview, we had the privilege of speaking with Dr. Thomas Powles, MD, a leading oncologist at Barts Health NHS Trust and the global lead investigator of…

    2025.05.08
  • “50 Years of Hematopoietic Stem Cell Transplantation”

    We were honored to hear from Professor Xiaojun Huang of Peking University People’s Hospital and the Peking University Institute of Hematology, who shared a comprehensive reflection on the global evolution of hematopoietic stem cell transplantation (HSCT). From Dr. Edward Donnall Thomas’ foundational work to the creation of the Beijing Protocol, Professor Huang spotlighted how China’s…

    2025.05.08
  • CSCO Guidelines Conference | Academician Jinming Yu: From the “Jinan Miracle” in Radiation Therapy to Advancing Immunotherapy and International Collaboration

    The 2025 CSCO Guidelines Conference, co-hosted by the Chinese Society of Clinical Oncology (CSCO) and the Beijing Xisike Clinical Oncology Research Foundation, was successfully held in Jinan, April 18–19, 2025. Leading experts from across the country gathered once again to exchange cutting-edge research, discuss clinical hot topics, and witness the release of updated CSCO guidelines.…

    2025.04.29
  • Exploring Leadership, Innovation, and the Future of Lung Cancer Research | Mo Wen Series

    2025.04.28
  • EAU 2025 | Professor Alicia K. Morgans: Challenges and Breakthroughs in Prostate Cancer Treatment

    UroStream: What are the current challenges in clinical practice for metastatic prostate cancer, and what breakthroughs have been achieved recently? Dr. Alicia K. Morgans: I think some of the biggest…

    2025.04.27
  • IHCAMS 2025 | International Workshop on Cell Therapy for Blood Diseases: Applications Now Open for Belt and Road Traineeship in Tianjin

    An international event focusing on cellular therapy for blood diseases is approaching! From August 17 to Sep 1, 2025, in Tuanbo Campus,Tianjin, China, the International Workshop on Cell Therapy of…

    2025.04.25
  • EAU 2025 | Professor Anders Kjellman: Biopsy Before Treatment Plays a Key Role in Managing Small Renal Masses (SRMs)

    Current Clinical Landscape: Biopsy Remains Underused in Small Renal Masses Despite advancements in imaging and surgical techniques, biopsy remains underutilized in the diagnosis of small renal masses (SRMs, ≤4 cm).…

    2025.04.25
«previous next»
Recent Posts
  • Professor Xinan Sheng: Advancing ADC Sequencing Strategies to Overcome Drug Resistance
  • Advancing Precision Therapy in Urothelial Carcinoma: A Collaborative Study by Professors Xuesong Li, Qi Tang, Jianhua Zhang, and Xiaoying Li Explores a Novel Approach to HER2 Assessment
  • Disitamab Vedotin–Based Combination Strategy Redefines First-Line Treatment for Advanced Urothelial Carcinoma, Nearly Doubling Overall Survival
  • 2025 Tianjin International Breast Cancer Conference | Prof. Jihui Hao: A Blueprint for Intelligent Breast Cancer Prevention and Care
  • 2025 Tianjin International Breast Cancer Conference | Prof. Zhongsheng Tong: Targeted Therapy Frontiers and the “Tianjin Experience”
Recent Comments
    Archives
    • January 2026
    • December 2025
    • November 2025
    • October 2025
    • September 2025
    • August 2025
    • July 2025
    • June 2025
    • May 2025
    • April 2025
    • March 2025
    • February 2025
    • January 2025
    • December 2024
    • November 2024
    • October 2024
    • September 2024
    • August 2024
    • July 2024
    • June 2024
    • May 2024
    • April 2024
    • March 2024
    • February 2024
    • January 2024
    • December 2023
    • November 2023
    • October 2023
    • August 2023
    Categories
    • Artificial intelligence
    • Hematology Frontier
    • Infectious Disease Frontier
    • International Hepatology
    • IOncology
    • Live broadcasting
    • Uncategorized
    • UroStream
    • LinkedIn
    • Twitter
    • Mail
    Related Media:
    Copyright 2026 — MediaMedic. All rights reserved. Blogun WordPress Theme
    Paris, France
    Scroll to Top